Physician profile
Grant Hsing
NPI 1568684322
$1,790.10
in general payments reported to CMS, 2019-2025
21 companies · $23.32 in 2025
The $23.32 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $334 · 2021: $202 · 2022: $90.55 · 2023: $13.22 · 2025: $23.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $373.50 | 2019-2021 | |
| Allergan, INC. | $195.29 | 2019-2020 | |
| Pfizer INC. | $191.83 | 2019 | |
| Lilly USA, LLC | $187.85 | 2019-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $178.71 | 2019-2020 | |
| Abbvie INC. | $155.21 | 2021-2022 | |
| Amgen INC. | $103.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.22 | 2019 | |
| Merck Sharp & Dohme LLC | $63.05 | 2019 | |
| Glaxosmithkline, LLC. | $59.31 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $32.18 | 2019 | |
| Medtronic USA, INC. | $22.46 | 2019 | |
| Horizon Therapeutics Plc | $18.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.95 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.17 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.14 | 2019 | |
| Exact Sciences Corporation | $13.22 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $12.55 | 2019 | |
| Zyla Life Sciences, INC. | $11.72 | 2019 | |
| Aytu Biopharma, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Hsing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.